Latest total current liabilities for REVBW: $1.4M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), REVBW shows a total current liabilities of $1.4M. That compares with $1.1M in the prior-year period — up 30.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, REVBW's total current liabilities is now $1.4M (was $1.1M) — a 30.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences- Warrants(10/01/2027) is outperforming or lagging.
Tracking REVBW's total current liabilities over time shows whether Revelation Biosciences- Warrants(10/01/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $1.1M in the prior-year period — up 30.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has Revelation Biosciences- Warrants(10/01/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.4M) with ownership activity and broader fundamentals.